Mandate

Vinge advises Bilia on refinancing

March 27, 2024 Banking and Finance

Vinge had advised Bilia AB (publ) in connection with the SEK 2.3 billion refinancing of its existing revolving loan and credit facilities.

The new credit facility amounts to SEK 2,300 million, with a split of SEK 1,700 million in revolving loans and SEK 600 million in overdraft loans. The revolving loans have a tenor three years with an extension option (one plus one years) upon the lenders approval. DNB and Nordea are the original lenders under the new credit facility.

Together with outstanding unsecured bonds of SEK 1,300 million, in relation to which Vinge has also advised Bilia, the credit facility constitutes a significant part of Bilia’s long-term core financing.

Vinge’s team consisted of Anders Strid, Lionardo Ojeda, Sofia Haggren and Frithiof Hallgren Wallin.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025